Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression
oleh: Ai-Tram N. Bui, BA, Caroline A. Nelson, MD, Christine G. Lian, MD, Alvaro Laga Canales, MD, MMSC, Nicole R. LeBoeuf, MD, MPH
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2020-08-01 |
Deskripsi
Subjek
autoimmunity; checkpoint inhibition; cutaneous toxicities; eosinophilic fasciitis; immune checkpoint inhibitors; immune-related adverse event